Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: A case report

Majd D. Jawad, Ronald S. Go, Rhett P. Ketterling, Kebede H. Begna, Kaaren K. Reichard, Min Shi

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Tyrosine kinase inhibitor treated chronic myelogenous leukemia patients with monosomy 7 arising in Philadelphia chromosome negative (Ph-) cells tend to evolve into MDS/AML. However, monosomy 7 in Ph- cells can be a transient finding, and it is not an absolute indication of the emergence of a new myeloid malignancy.

Original languageEnglish (US)
Pages (from-to)282-286
Number of pages5
JournalClinical Case Reports
Volume4
Issue number3
DOIs
StatePublished - Mar 1 2016

Keywords

  • Chronic myelogenous leukemia
  • Monosomy 7

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Transient monosomy 7 in a chronic myelogenous leukemia patient during nilotinib therapy: A case report'. Together they form a unique fingerprint.

  • Cite this